Baird analyst David Rescott downgraded Inspire Medical Systems (NYSE: INSP) from Outperform to Neutral with a price target of $74.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE